SCHEMBL8083748

SCHEMBL8083748

C=C(Nc1cccc(Cl)c1)c1cnc(NCC)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.43
MAPT P10636 6/20 0.42
KMT2A Q03164 6/20 0.41
MEN1 O00255 5/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 2/20 0.41
ALDH1A1 P00352 1/20 0.41
P2RY12 Q9H244 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
P4HTM Q9NXG6 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
EEF2K O00418 1/20 0.40
PLK1 P53350 1/20 0.40
EPHX1 P07099 3/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4251689 0.86 P4HTM (0.55) MAPTKMT2AMEN1LMNAHTT
SCHEMBL8078603 0.85 VNN1 (0.48) EGFRMAPTKMT2AMEN1LMNA
SCHEMBL8088414 0.83 KMT2A (0.41) MAPTKMT2AMEN1LMNAHTT
SCHEMBL3643499 0.81 P4HTM (0.50) MAPTKMT2AMEN1ALDH1A1NPC1
SCHEMBL8071307 0.79 MAPKAPK2 (0.46) MAPTKMT2AMEN1LMNAHTT
SCHEMBL8071311 0.78 MEN1 (0.43) MAPTKMT2AMEN1LMNAHTT
SCHEMBL4247747 0.77 P4HTM (0.53) MAPTKMT2AMEN1ALDH1A1NPC1
SCHEMBL8082051 0.75 HCAR3 (0.49) EGFRMAPTKMT2AMEN1ALDH1A1
SCHEMBL3646879 0.75 EPHX1 (0.53) MAPTALDH1A1NPC1RAB9AP4HTM
SCHEMBL8081028 0.74 HCAR3 (0.51) MAPTKMT2AMEN1P4HTMEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009016088-A1 THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2009-02-05 WO disclosed